Is Buying Proteostasis Therapeutics Inc (NASDAQ:PTI), Having Higher Short Interest a Winning Strategy?

Proteostasis Therapeutics, Inc. (NASDAQ:PTI) Logo

The stock of Proteostasis Therapeutics Inc (NASDAQ:PTI) registered an increase of 15.45% in short interest. PTI’s total short interest was 3.98M shares in July as published by FINRA. Its up 15.45% from 3.45M shares, reported previously. With 2.06 million shares average volume, it will take short sellers 2 days to cover their PTI’s short positions.

The stock decreased 0.99% or $0.01 during the last trading session, reaching $1. About 448,933 shares traded. Proteostasis Therapeutics, Inc. (NASDAQ:PTI) has declined 78.57% since July 12, 2018 and is downtrending. It has underperformed by 83.00% the S&P500.

Proteostasis Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics that treat diseases caused by dysfunctional protein processing, such as cystic fibrosis. The company has market cap of $51.10 million. The Company’s lead product candidate is PTI-428, an orally bioavailable cystic fibrosis transmembrane conductance regulator modulator belonging to the amplifier class that is in Phase-I studies. It currently has negative earnings. The firm is also developing PTI-801, a corrector molecule; PTI-808, a potentiator molecule; and unfolded protein response modulators that are in preclinical development.

More notable recent Proteostasis Therapeutics, Inc. (NASDAQ:PTI) news were published by: Nasdaq.com which released: “Proteostasis Therapeutics (PTI) Reports Q1 Loss, Tops Revenue Estimates – Nasdaq” on May 08, 2019, also Seekingalpha.com with their article: “Proteostasis up 24% on BlackRock stake – Seeking Alpha” published on February 11, 2019, Prnewswire.com published: “Proteostasis Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update – PRNewswire” on May 08, 2019. More interesting news about Proteostasis Therapeutics, Inc. (NASDAQ:PTI) were released by: Seekingalpha.com and their article: “Proteostasis Therapeutics Delivered 400% Stock Returns – Seeking Alpha” published on October 19, 2018 as well as Globenewswire.com‘s news article titled: “Pain Therapeutics Reports 2018 Financial Results and Corporate Update – GlobeNewswire” with publication date: March 25, 2019.

Proteostasis Therapeutics, Inc. (NASDAQ:PTI) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.